Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile

Date: February 13, 2018
Pages: 108
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: SDDFD8807C2EN
Leaflet:

Download PDF Leaflet

Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile
Summary

Sanofi is a healthcare company, which focuses on researching, developing, manufacturing and marketing of a wide range of medicines and vaccines. Its product portfolio includes medicines for the treatment of cancer, diabetes, rare diseases, multiple sclerosis and cardiovascular diseases; human vaccines for protection against various bacterial and viral diseases; and other products. The major products of the company include Aubagio, Lantus, Lovenox, Plavix and others. Sanofi also offers consumer healthcare products for digestion; allergy; cough, cold, flu and sinus; pain; women’s health; and vitamins, minerals and supplements. It has operations across Europe, the Americas, Asia-Pacific, Africa and the Middle East. Sanofi is headquartered in Paris, France.

Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.

NOTE: Out of security concerns GlobalData requires using corporate email address.
Sanofi, Medical Equipment, Deals By Year, 2012 to YTD 2018
Sanofi, Medical Equipment Deals By Type, 2012 to YTD 2018
Sanofi, Medical Equipment, Deals By Region, 2012 to YTD 2018
Sanofi, Medical Equipment, Deals By Market, 2012 to YTD 2018
Sanofi, Medical Equipment, Deals Summary, 2012 to YTD 2018
Sanofi, Medical Equipment, Deal Details
Asset Purchase
Sanofi Plans to Acquire Medical Device Assets
Venture Financing
Portal Instruments Raises USD25 Million in Series B Financing
Portal Instruments Raises USD11 Million in Series A Venture Financing
Partnerships
Berg Enters into Research Agreement with Sanofi
Sanofi and Voluntis Enter into Agreement
Sanofi and Verily Life Sciences Form Joint Venture
Global Genomics Enters into Research Agreement with Sanofi
Google Life Sciences Enters into Agreement with Sanofi
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System
Sanofi Enters into Co-Development Agreement with Medtronic
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments
HTG Molecular Diagnostics Enters Into Co-Development Agreement With sanofi-aventis
Genzyme Extends Co-Promotion Agreement with Veracyte
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics
Merger
Sanofi Japan and Genzyme Japan Merge
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology
Equity Offering
JHL Biotech Raises USD80 Million in Private Placement of Shares
Alnylam Pharma Raises USD70.7 Million in Private Placement of Shares
Debt Offering
Sanofi Prices Public Offering of Notes Due 2019 for USD850 Million
Sanofi Prices Public Offering of 1.5% Notes Due 2025 for USD850 Million
Sanofi Prices Public Offering of 1.75% Notes Due 2026 for USD1.64 Billion
Sanofi Prices Public Offering of 1.125% Notes Due 2022 for USD1.31 Billion
Sanofi Prices Public Offering Of Bonds Due 2023 For US$1.35 Billion
Sanofi Prices Public Offering Of Bonds Due 2020 For US$1.3 Billion
Sanofi Completes Public Offering Of Notes Due 2018 For US$1.5 Billion
Sanofi Completes Public Offering Of Notes Due 2017 For US$960 Million
Asset Transactions
Lupin May Acquire Pulmojet from Zentiva
Acquisition
Sanofi to Acquire Bioverativ for USD11.5 Billion in Tender Offer
Sanofi-Aventis To Acquire Minority Stake In Shantha Biotechnics For US$123 Million
L'Oreal Plans To Sell Its Stake In Sanofi
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb
Sanofi Completes Acquisition Of Pluromed
Sanofi - Key Competitors
Sanofi - Key Employees
Sanofi - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
Financial Announcements
Nov 02, 2017: Sanofi: Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed
Jul 31, 2017: Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER
Jul 12, 2017: Sanofi: Pre-quarterly Results Communication
Apr 28, 2017: Sanofi Delivers Robust Q1 2017 Financial Results
Feb 08, 2017: Sanofi Delivers 2016 Sales and Business EPS Growth at CER
Corporate Communications
Jan 19, 2018: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee
Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia
Apr 11, 2017: Sanofi Announces Pre-quarterly Results Communication
Apr 05, 2017: Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee
Mar 02, 2017: Sanofi’s Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charles as New Independent Directors
Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK
Jan 30, 2017: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs
Other Significant Developments
Feb 07, 2018: Sanofi Delivers 2017 Business EPS in line with Guidance
Nov 16, 2017: Blue Cross and Blue Shield Companies Partner with Onduo on Three State Pilot Programs to Address Diabetes
Sep 25, 2017: Innovation Health Announces Pilot Program with Sanofi to Improve Care Delivery for People Living with Type 2 Diabetes
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Sanofi, Medical Equipment, Deals By Year, 2012 to YTD 2018
Sanofi, Medical Equipment Deals By Type, 2012 to YTD 2018
Sanofi, Medical Equipment, Deals By Region, 2012 to YTD 2018
Sanofi, Medical Equipment, Deals By Market, 2012 to YTD 2018
Sanofi, Medical Equipment, Deals Summary, 2012 to YTD 2018
Sanofi, Medical Equipment, Deal Details
Asset Purchase
Sanofi Plans to Acquire Medical Device Assets
Venture Financing
Portal Instruments Raises USD25 Million in Series B Financing
Portal Instruments Raises USD11 Million in Series A Venture Financing
Partnerships
Berg Enters into Research Agreement with Sanofi
Sanofi and Voluntis Enter into Agreement
Sanofi and Verily Life Sciences Form Joint Venture
Global Genomics Enters into Research Agreement with Sanofi
Google Life Sciences Enters into Agreement with Sanofi
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System
Sanofi Enters into Co-Development Agreement with Medtronic
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments
HTG Molecular Diagnostics Enters Into Co-Development Agreement With sanofi-aventis
Genzyme Extends Co-Promotion Agreement with Veracyte
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics
Merger
Sanofi Japan and Genzyme Japan Merge
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology
Equity Offering
JHL Biotech Raises USD80 Million in Private Placement of Shares
Alnylam Pharma Raises USD70.7 Million in Private Placement of Shares
Debt Offering
Sanofi Prices Public Offering of Notes Due 2019 for USD850 Million
Sanofi Prices Public Offering of 1.5% Notes Due 2025 for USD850 Million
Sanofi Prices Public Offering of 1.75% Notes Due 2026 for USD1.64 Billion
Sanofi Prices Public Offering of 1.125% Notes Due 2022 for USD1.31 Billion
Sanofi Prices Public Offering Of Bonds Due 2023 For US$1.35 Billion
Sanofi Prices Public Offering Of Bonds Due 2020 For US$1.3 Billion
Sanofi Completes Public Offering Of Notes Due 2018 For US$1.5 Billion
Sanofi Completes Public Offering Of Notes Due 2017 For US$960 Million
Asset Transactions
Lupin May Acquire Pulmojet from Zentiva
Acquisition
Sanofi to Acquire Bioverativ for USD11.5 Billion in Tender Offer
Sanofi-Aventis To Acquire Minority Stake In Shantha Biotechnics For US$123 Million
L'Oreal Plans To Sell Its Stake In Sanofi
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb
Sanofi Completes Acquisition Of Pluromed
Sanofi - Key Competitors
Sanofi - Key Employees
Sanofi - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
Financial Announcements
Nov 02, 2017: Sanofi: Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed
Jul 31, 2017: Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER
Jul 12, 2017: Sanofi: Pre-quarterly Results Communication
Apr 28, 2017: Sanofi Delivers Robust Q1 2017 Financial Results
Feb 08, 2017: Sanofi Delivers 2016 Sales and Business EPS Growth at CER
Corporate Communications
Jan 19, 2018: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee
Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia
Apr 11, 2017: Sanofi Announces Pre-quarterly Results Communication
Apr 05, 2017: Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee
Mar 02, 2017: Sanofi’s Board of Directors Proposes Appointment of Melanie Lee, PhD and Bernard Charles as New Independent Directors
Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK
Jan 30, 2017: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs
Other Significant Developments
Feb 07, 2018: Sanofi Delivers 2017 Business EPS in line with Guidance
Nov 16, 2017: Blue Cross and Blue Shield Companies Partner with Onduo on Three State Pilot Programs to Address Diabetes
Sep 25, 2017: Innovation Health Announces Pilot Program with Sanofi to Improve Care Delivery for People Living with Type 2 Diabetes
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF FIGURES

Sanofi, Medical Equipment, Deals by Type, 2012 to YTD 2018
Sanofi, Medical Equipment, Deals By Year, 2012 to YTD 2018
Sanofi, Medical Equipment, Deals By Region, 2012 to YTD 2018
Sanofi, Medical Equipment, Deals By Market, 2012 to YTD 2018
Sanofi, Medical Equipment, Deals By Year, 2012 to YTD 2018
Sanofi, Medical Equipment, Deals by Type, 2012 to YTD 2018
Sanofi, Medical Equipment, Deals By Region, 2012 to YTD 2018
Sanofi, Medical Equipment, Deals by Market, 2012 to YTD 2018
Skip to top


Ask Your Question

Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: